MRM Health scores FDA green light to launch Phase 2b trial of groundbreaking UC therapy
MH002, a rationally designed live microbial consortium, combines six well-characterized commensal strains to target disease-specific mechanisms
MH002, a rationally designed live microbial consortium, combines six well-characterized commensal strains to target disease-specific mechanisms
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The accelerated review covers WCK 5222 for multiple critical infections
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
The reform is set to modernise how medicines are developed, authorised, and made available across the EU
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
Captured microbes are then neutralized on engineered microbicidal surfaces
Surgical site infections and antimicrobial resistance remain major challenges globally
The new Bioprocess Design Center will serve as a cutting-edge scale-up hub for biologics and vaccine manufacturing
Subscribe To Our Newsletter & Stay Updated